TruPlan vs Reveal LINQ

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Circle Cardiovascular Imaging Inc.
VS
by Medtronic

AI Verdict

TruPlan is an AI-enabled CT imaging software designed for comprehensive pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures, focusing on anatomical assessment and simulation. In contrast, Reveal LINQ is an implantable cardiac monitor that continuously records ECG, utilizing AI algorithms to detect and diagnose cardiac arrhythmias over an extended period. While both leverage AI in cardiology, TruPlan serves interventional planning, whereas Reveal LINQ is a diagnostic tool for rhythm disorders.

Choose TruPlan if…

Choose TruPlan if your clinical practice requires advanced AI-enabled CT imaging software for precise pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures. This tool is ideal for cardiologists and cardiac surgeons needing detailed 3D anatomical assessment, automated LAA landing zone definition, and simulation capabilities to optimize LAAC device selection and placement.

View TruPlan →

Choose Reveal LINQ if…

Choose Reveal LINQ if you need a long-term, continuous cardiac monitoring solution for patients experiencing infrequent or unexplained symptoms suggestive of cardiac arrhythmias, such as cryptogenic stroke or syncope. This tiny implantable cardiac monitor, with its AI-powered AccuRhythm™ algorithms, is best suited for accurately detecting and diagnosing elusive arrhythmias over an extended period of up to three years.

View Reveal LINQ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature TruPlan Reveal LINQ
Pricing Unknown Contact vendor
Deployment Standalone software on desktop/laptop or server within hospital infrastructure with thick-client software on multiple desktops/laptops. It runs locally without an internet connection, though license key activation requires a direct internet connection. The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

TruPlan

TruPlan, as a dedicated software application, offers a more direct and controlled user experience for clinicians focused on pre-procedural planning. Its usability is centered on intuitive interaction with advanced visualization and measurement tools. In contrast, Reveal LINQ involves a more complex ecosystem spanning an invasive procedure, patient device interaction, and clinician mobile app management.

Clinical Value

Reveal LINQ

While both tools offer significant clinical value, Reveal LINQ's ability to provide continuous, long-term, AI-powered diagnostic capabilities for often asymptomatic or paroxysmal arrhythmias can lead to earlier diagnosis and treatment for conditions that might otherwise go undetected. This has a potentially broader impact on patient outcomes by enabling critical diagnoses. TruPlan, while optimizing an intervention, serves a more focused procedural planning role.

Pricing & Value

TruPlan

TruPlan potentially offers a significant pricing advantage as it 'may be accessible at no additional cost through Boston Scientific representatives' for WATCHMAN procedures. Additionally, Circle CVI's broader cvi42 platform offers a flexible subscription model. While Reveal LINQ's costs are typically integrated into procedure costs and covered by insurance, the possibility of no additional cost for TruPlan presents a more direct and potentially favorable value proposition.

Enterprise Readiness

TruPlan

TruPlan explicitly states it 'has_baa': '1' and offers on-premise deployment, which can be a key requirement for many healthcare enterprises seeking direct control over data and clear contractual agreements. While Medtronic is a large, established company with implied HIPAA compliance for its devices, the explicit BAA statement for TruPlan provides a clearer indication of its readiness for enterprise-level data governance agreements.

Innovation

Reveal LINQ

Reveal LINQ demonstrates a higher degree of innovation by combining extreme miniaturization ('world's smallest insertable cardiac monitor'), long-term continuous monitoring for up to three years, and AI-powered diagnostic accuracy within an implantable medical device. This represents a more significant advancement in integrated hardware and AI for patient monitoring. TruPlan's software-based AI for image analysis, while cutting-edge, is a different type of innovation.

Support & Docs

Reveal LINQ

Medtronic offers a highly structured and comprehensive support system for Reveal LINQ, including 24-hour product technical support lines and dedicated patient services. They also provide an extensive online manual library covering various aspects of the implantable device. While Circle CVI emphasizes 'world class support' with a global team and documentation, Medtronic's explicit and multi-faceted support channels for a complex implantable device provide a slight edge in terms of readily available and detailed resources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature TruPlan Reveal LINQ
Primary Function/Purpose AI-enabled CT imaging software for comprehensive pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures. Tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AI algorithms to accurately detect and diagnose cardiac arrhythmias.
Company Circle Cardiovascular Imaging Medtronic
Tagline Enhancing Healthcare Outcomes by Unlocking Data Insights from Medical Imaging Procedures to Empower Efficient and Reliable Decision-Making. The world's smallest insertable cardiac monitor with AI-powered accuracy.
Categories Cardiology AI, Radiology & Imaging AI, Surgical AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Cardiothoracic Surgery, Radiology Cardiology, Neurology
Key Features (Examples) AI-enabled Left Heart Segmentation, Automated LAA Landing Zone Definition, TEE Simulation World's smallest insertable cardiac monitor, Continuous ECG monitoring for up to three years, AccuRhythmu2122 AI algorithms for reduced false alerts

Videos

Demos, reviews, and walkthroughs featuring TruPlan and Reveal LINQ.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

TruPlan is an AI-enabled CT imaging software designed for comprehensive pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures. In contrast, Reveal LINQ is a tiny, implantable cardiac monitor used for continuous ECG recording to detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope.
TruPlan utilizes AI-enabled CT imaging software to provide advanced visualization and measurement tools for anatomical assessment of the heart and vessels. Reveal LINQ is an implantable medical device that continuously records ECG data for up to three years, employing AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias.
TruPlan is specifically designed for adult patients undergoing Left Atrial Appendage Closure (LAAC) procedures, aiding in planning and post-procedural assessment. Reveal LINQ is indicated for patients experiencing transient symptoms such as dizziness, palpitations, syncope, and chest pain that may suggest a cardiac arrhythmia, as well as those at increased risk for cardiac arrhythmias, offering long-term monitoring.
TruPlan offers AI-enabled left heart segmentation, automated LAA landing zone definition, 3D anatomical assessment, and simulations of TEE, ICE, and fluoroscopic views for procedural planning. Reveal LINQ provides continuous ECG monitoring data and uses AI algorithms to reduce false alerts for atrial fibrillation and pauses, offering automatic and patient-activated event recording.
AI Tool Finder
AI-powered search. Results may not be comprehensive.